A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis

Status:
Completed

Trial end date:
2008-06-17

Target enrollment:

Participant gender:

This study will evaluate the effectiveness and safety of denosumab in treating women with Postmenopausal Osteoporosis.

Phase 3

Amgen

Denosumab